EU pledges €225m to develop next generation of flu vaccines - Pharmaceutical Technology

Europe accelerates next-generation flu vaccines with €225m innovation procurement push - European Biotechnology Magazine

A group of vaccine developers, biotech firms and public health institutes, including Bavarian Nordic and Sanofi, has secured framework contracts under a €225 million EU initiative to accelerate the development of next-generation influenza vaccines. The post Europe accelerates next-generation flu vaccines with €225m innovation procurement push appeared first on European Biotechnology Magazine.

EU pledges €225m to develop next generation of flu vaccines - Pharmaceutical Technology

Sanofi and Bavarian Nordics are amongst the recipients of eight-year EU vaccine contracts that will help bring new products to market.

EU invests €225m to deliver next-generation influenza vaccines

Next-gen influenza vaccines offer protection against a wider range of flu variants and can be quickly adapted if a new strain emerges.